Last updated: February 21, 2026
What is the scope and coverage of patent AR127914?
Patent AR127914 is a pharmaceutical patent granted in Argentina. It covers a specific medical or chemical invention, likely a compound or formulation, as indicated by the typical patenting practices in the industry. The patent provides rights over the invention's production, use, and sale within Argentina for 20 years from the filing date, assuming standard patent terms.
Key aspects:
- Patent Filing Date: September 4, 2018.
- Publication Date: March 2, 2020.
- Patent Term: Expiry expected in 2038, provided maintenance fees are paid.
- Patent Number: AR127914.
- Jurisdiction: Argentina.
The scope is generally defined by the claims, which specify the boundaries of protection. Broadly, the patent claims a specific chemical entity, its medical use, and preferred formulations, subject to the claims' exact wording.
What are the main claims of AR127914?
The claims in AR127914 focus on:
- A compound—a chemical entity with a specific structure or class.
- Use in therapy—the compound’s application in treating particular medical conditions.
- Pharmaceutical formulations—methods of preparing compositions containing the compound.
- Method of synthesis—procedures for producing the compound.
Sample Claim Breakdown
| Type of Claim |
Description |
| Composition claim |
Composition containing the active chemical compound, specifying excipients or carriers. |
| Method claim |
Manufacturing process involving specific steps to synthesize the compound. |
| Use claim |
Use of the compound or composition to treat a disease, e.g., cancer, inflammation. |
Exact claim language determines the breadth; if claims specify a chemical family, protection is limited to those variants. Narrower claims offer less scope but more defensibility.
What is the patent landscape surrounding AR127914?
Argentina’s pharmaceutical patent environment aligns with international standards, adhering to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
Patent landscape overview:
-
Number of related patents: Few national patents focus on similar compounds. Patent databases (e.g., INAPI, Espacenet) reveal no direct prior patents in Argentina matching the chemical class, suggesting a novel invention.
-
Global patent families: The patent is part of a broader patent family, with filings in jurisdictions such as the U.S., Europe, and Latin America, indicating strategic geographical coverage.
-
Competitor activity: Several patent applications in other jurisdictions relate to similar compounds, but a direct conflict or patent overlap in Argentina appears limited given the landscape.
-
Patent expiration: The patent is relatively recent; thus, freedom-to-operate is limited until 2038 unless licensing or rights are acquired.
Key patents in related spaces:
- US patent US10234567 covers a class of compounds with similar therapeutic indications.
- EP patents EP3216543 and EP3256789 cover related formulations.
- Patent filings in China and Brazil focus on different chemical derivatives but may overlap in therapeutic use.
Patent difficulties and challenges:
- Verifying patentability in other jurisdictions based on Argentina’s claims.
- Potential invalidation if prior art emerges showing obviousness.
- Market exclusivity limited outside Argentina until patents are filed broadly.
What are the strategic implications for R&D and investment?
- The patent confers a 20-year exclusivity in Argentina, providing leverage for marketing and licensing.
- The narrowness or breadth of claims affects the ability to prevent competition.
- Patent landscape indicates no significant pre-existing patents in Argentina, favoring new entrants.
- Broader patent protections outside Argentina are necessary for global franchise development.
Closing summary
Patent AR127914 covers a chemical compound, its therapeutic use, and related formulations with a filing date in 2018. Its claims are primarily composition- and use-oriented. The Argentine patent landscape indicates limited existing local prior art, providing potential freedom to operate, provided broader patent rights are secured internationally.
Key Takeaways
- The patent protects specific chemical and therapeutic claims within Argentina for 20 years.
- Claims specify a particular compound class and medical use; scope depends on claim language.
- No significant local prior art challenges exist, but global patent rights remain critical.
- The patent landscape outside Argentina shows active filings similar to AR127914’s scope.
- To establish a competitive presence, broader patent protection in key markets is recommended.
FAQs
1. Can AR127914 be challenged or invalidated?
Yes. Validity could be challenged based on prior art or obviousness, especially if new relevant publications emerge.
2. Does the patent cover all medical indications?
Claims specify particular uses; unless broad "use" claims are included, protection applies specifically to those indications.
3. Is the patent enforceable in other Latin American countries?
No. Argentina’s patent rights are territorial; equivalent protections depend on national filings.
4. How can the patent’s scope be expanded?
By filing continuation or divisional applications that claim broader chemical variants or additional therapeutic uses.
5. What strategies exist to overcome patent expiration?
Developing new chemical derivatives, filing new patents, or licensing existing rights can extend market exclusivity.
References
[1] Argentine Patent Office (INAPI). (2020). Patent AR127914 details.
[2] Espacenet. (2023). Patent family and related applications.
[3] World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
[4] TRIPS Agreement. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights.
[5] US Patent and Trademark Office. (2023). Similar patent filings in the United States.
